Cite
HARVARD Citation
Sverak, P. et al. (2019). Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient‐Reported Outcomes and Toxicities. Otolaryngology--head and neck surgery. pp. 526-532. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sverak, P. et al. (2019). Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient‐Reported Outcomes and Toxicities. Otolaryngology--head and neck surgery. pp. 526-532. [Online].